- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/78 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
Patent holdings for IPC class C07C 235/78
Total number of patents in this class: 123
10-year publication summary
15
|
9
|
9
|
10
|
3
|
8
|
7
|
6
|
7
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
PTC Therapeutics, Inc. | 481 |
12 |
Theravance Biopharma R&D IP, LLC | 462 |
6 |
Chem-Master International, Inc. | 11 |
5 |
Vectus Biosystems Limited | 35 |
5 |
Annji Pharmaceutical Co., Ltd. | 15 |
4 |
The Regents of the University of California | 19812 |
3 |
Indiana University Research and Technology Corporation | 796 |
3 |
The Research Foundation for The State University of New York | 1603 |
3 |
The Research Foundation of State University of New York | 459 |
3 |
Zhejiang Huahai Pharmaceutical Co., Ltd. | 205 |
3 |
Apexian Pharmaceuticals, Inc. | 3 |
3 |
Novocodex Biopharmaceuticals Co., Ltd. | 11 |
3 |
F. Hoffmann-La Roche AG | 7926 |
2 |
Northwestern University | 3364 |
2 |
Dana-Farber Cancer Institute, Inc. | 2553 |
2 |
East Carolina University | 179 |
2 |
Edison Pharmaceuticals, Inc. | 37 |
2 |
Givaudan SA | 1853 |
2 |
Sunshine Lake Pharma Co., Ltd. | 588 |
2 |
Taisho Pharmaceutical Co., Ltd. | 862 |
2 |
Other owners | 54 |